The global dialysis catheters market was valued at USD 675.9 million in 2019 and is expected to grow at a CAGR of 4.8% during the forecast period. The market is driven by several factors such as increasing incidence of Chronic Kidney Disorders (CKDs), technological innovations such as development of dialysis catheters with anti-microbial coatings and rapidly increasing ageing population. The increase in the number of patients with various kidney disorders is increasing at a rapid pace due to changes in lifestyle and food intake.
The market has evolved in developed countries and has a large opportunity to grow in emerging economies. Players are currently focusing on increasing the number of dialysis centers, advancing treatment modes, and incorporating novel technologies in renal dialysis products to improve the patient's quality of life.
Kidney failure or any injury to the kidneys can cause serious complications such as hemorrhage, infection, or even multiple myelomas. Dialysis works like an artificial kidney that helps to discard the waste, such as creatinine and nitrogen, and excess water from the body when the kidneys malfunction. With the help of a dialysate fluid, the waste is removed from the blood without removing the substances that the body needs.
Know more about this report: request for sample pages
The growing prevalence of CKDs will increase the demand for dialysis catheters globally. The recent data estimated by CDC shows that nearly 29 million Americans have diabetes and one out of four are not aware of their condition. Globally, 50% of the dialysis patient population are found in the US, China, Japan, Brazil, and Mexico. ESRD is more prevalent among people aged above 70 years.
In 2016, Center for Disease and Control (CDC) estimated, the number of patients being treated for End Stage Renal Disorder (ESRD) worldwide at nearly 3,400,000 and is expected to grow at a rate of 6% every year. In 2017, CDC estimated 10% of the U.S. adults were affected with CKD. In addition, the number of people with diabetes is increasing in developing countries of APAC and Latin America owing to the changes in lifestyle. These diseases require regular dialysis or a kidney transplant.
The growth of the global dialysis catheters market has been curtailed by the presence of alternative treatment options, such as AV fistulas and AV grafts, for vascular access. Another key challenge in the market is the potential complications associated with the use of dialysis catheters such as misplacement, thrombosis, infection and dislodgement of the catheters.
Furthermore, few more negative effects are associated with peritoneal dialysis (PD) such as peritonitis, weight gain, muscles cramps, hernia, hypertension, itching, infections, fluid overload, and bone diseases. The main reason behind peritonitis is microbe invasion into peritoneal cavity entered via catheters.
The market is primarily segmented on the basis of product type, by application, by end-use, and geographic region.
By Product Type
Know more about this report: request for sample pages
Based upon the application, the global market is categorized into hemodialysis and peritoneal dialysis. In 2019, hemodialysis segment accounted for the majority of the share in the global market, and the segment is likely to maintain its dominance over the study period. Hemodialysis is a process that removes toxic substances, such as urea, from the blood of patients with renal failure. It brings back the balance of electrolytes in the blood. During hemodialysis, the toxins in blood are flushed out of the body with the help of renal solution when the blood flows through the dialyzer machine or artificial kidney. Usually, patients require hemodialysis three times a week, on an average of 3 to 4 hours of dialysis. The segment is driven by its high adoption in hospitals owing to its high efficiency.
Based upon the product, the global market is categorized into tunneled, non-tunneled, step-tip, split-tip, symmetric catheters. In 2019, the tunneled catheters segment accounted for the majority of share, owing to its high usage in hemodialysis process and longer durability. Tunneled catheters are frequently used, most often, 3 times a week for the chronic patients undergoing hemodialysis, which ultimately increases it consumption.
On the basis of end use, the global market is categorized into in-center, and home dialysis. The in-center dialysis is further segmented into hospitals and dialysis centers. In 2019, the in-center dialysis segment accounted for the largest share. In-center dialysis offers staff-assisted treatment, labs, and check-ups all in one place. This segment primarily includes hospitals and dialysis centers. These centers offer services during the day or at night while a patient is at resting stage and depending on patient convenience.
Geographically, the global market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). North America region is the largest revenue contributor followed by Europe and the Asia Pacific region. In 2019, the North America region accounted for more than 40% of the global market.
The prevalence of CKDs and the rise in kidney failure cases are the main reasons for this steady growth. Also, the growing demand for advanced dialysis catheters, innovations in designing tips for example, spiral-z tip, are driving the market in this region. Advanced products such as Tal PALINDROME Dual Lumen Catheters developed by Medtronic with spiral-z tips delivers high-flow rates with low vein and artery pressures. The positive reimbursement scenario has also contributed to the growth of the market in the region.
Also, the sales of the tunneled cuffed catheters, especially in the U.S., have increased due to the growing awareness about risks and infection spread through catheters. The established players are strategically launching the new products to increase their market share. Furthermore, the incidence of diabetes in Canada is gradually increasing, which will boost the sales of tunneled cuffed catheters in the region.
APAC is the lucrative market for the global market. The major countries contributing to the revenue of this region are Japan, South Korea, India, and China. The key factors driving the region’s growth are huge patient pool patient suffering with kidney related disorders, increase in elderly care centers, private dialysis centers with improving healthcare infrastructure, and ever increasing insurance penetration with rising per capita income. Japan is the largest developed market for dialysis catheters in APAC, owing to the high percentage of older adult population, who are prone to kidney diseases. It is also due to the wide network and high adoption rate of dialysis centers. Also, the uptake of home dialysis is relatively high in Japan compared with other countries such as India and China.
The global dialysis catheters market is fragmented due to the presence of diversified international and local vendors. The prominent players operating in the market are Fresenius Medical Care, NIPRO Medical Corporation, DaVita, Medical Components Inc., NIKKISO CO., LTD, B. Braun, Foshan Special Medical, Toray Medical, Jiangxi Sanxin Medtec, AngioDynamics Inc., Asahi Kasei Medical Co., Ltd., Baxter International, NxStage Medical, Inc., Shenzhen Shunmei Medical Technology., Outset Medical, Inc. and ALLMED MEDICAL CORP.
The market is witnessing intense competition from several large, medium, and small manufacturers as they provide dialysis products and services. The vendors also adopt collaborations and charges premium prices to stay competitive in the market. The companies are coming up with innovative features such as antimicrobial coated dialysis catheters to minimize the device borne infections. Local players in low income countries are providing low cost models to counter multi-national companies.